Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.54
Delayed Data
As of Feb 23
 -0.0166 / -1.07%
Today’s Change
1.47
Today|||52-Week Range
10.90
-11.49%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close1.56
Today’s open1.55
Day’s range1.50 - 1.59
Volume116,090
Average volume (3 months)511,393
Market cap$18.3M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+35.19%
Earnings growth (this year)+35.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-56.64%
P/E ratioNM
Price/Sales21.49
Price/Book0.46

Competitors

 Today’s
change
Today’s
% change
KTOVKitov Pharma Ltd+0.07+2.68%
ACSTAcasti Pharma Inc+0.00+0.33%
HTBXHeat Biologics Inc-0.24-8.43%
DAREDare Bioscience Inc0.000.00%
Data as of 3:59pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$843.0K
Annual profit (last year)-$11.8M
Net profit margin-1,398.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts